DHSC letter to medicines and medical product suppliers regarding the ending of the transition period
The Department of Health and Social Care’s (DHSC) Chief Commercial Officer, Steve Oldfield, has written a letter to medicines and medical product suppliers regarding the continued preparations ahead of the end of the transition period on 31 December 2020.
The letter begins by reiterating the importance of both UK and EU traders being prepared for new processes and formalities to ensure disruption does not occur.
The letter goes on to outline the multi-layered approach the government is putting in place to ensure the continuity of the supply of medicines and medical products to patients across the UK and its Crown Dependencies.
These border planning assumptions include:
- Alternative routes, such as government-secured freight capacity and an express freight service for the urgent movement of medicines and medical products,
- Supporting trader readiness for the new customs and border processes,
- Buffer stocks of medical supplies where possible part of industry contingency plans,
- Regulation, including a phased process for implementing medicines regulation in Northern Ireland, and
- Shortage management responses, through the continued to raising of anticipated or actual supply disruption and the close collaboration between MHRA, NHS England and Improvement and suppliers to ensure the supply chain is managed and risks to patients are minimised.
For more information, please read the DHSC letter.